These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1225061)

  • 1. [Methods for determining the effect of cytostatic drugs on genital carcinoma in vitro].
    Spitzbart H
    Akush Ginekol (Sofiia); 1975; 14(1):61-2. PubMed ID: 1225061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antineoplastic therapy of neoplasms in the female genital sphere: considerations on results of the Figlu test].
    Sacco O; Colavita D; Ferrarese R
    Arch Ostet Ginecol; 1970 Dec; 75(6):466-73. PubMed ID: 5535801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic therapy of gynecological carcinoma].
    Vahrson H
    Fortschr Med; 1974 Mar; 92(9):363-8. PubMed ID: 4206636
    [No Abstract]   [Full Text] [Related]  

  • 4. [Registration of cytostatic effects in vitro by means of an objective method of cell counting (ZZV) (author's transl)].
    Krafft W; Preibsch W; Marzotko F; Niedner K
    Arch Geschwulstforsch; 1974; 44(2):140-3. PubMed ID: 4476203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytostatic treatment of genital carcinoma].
    Limburg H
    Zentralbl Gynakol; 1969 Sep; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of 15 antineoplastic drugs on colon carcinoma growing in vitro: a screening assay for cytotoxicity (author's transl)].
    Gouget N; Jeannin JF; Olsson O; Martin F
    Bull Cancer; 1980; 67(2):155-60. PubMed ID: 7448437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problem of screening of antineoplastic drugs in tissue and cell cultures].
    Dobrynin IaV
    Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
    Krafft W; Preibsche W; Marzotko F
    Arch Geschwulstforsch; 1973; 41(3):241-7. PubMed ID: 4732846
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience in chemotherapy with celioclysis of ascitic tumors of the female genital system].
    Baisi F; Macchia A; Palagi R
    Minerva Ginecol; 1970 Feb; 22(4):264-8. PubMed ID: 5421818
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of determining the sensitivity of hypernephroid cancer to cytostatic agents in vitro and clinically].
    Terent'eva TG; Matveev BP; Martochkina GA; Marinbakh EB
    Antibiotiki; 1977 Jul; 22(7):648-52. PubMed ID: 329755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytostatic therapy in gynecology].
    Shturkalev I; Vasilev B
    Akush Ginekol (Sofiia); 1966; 5(6):405-14. PubMed ID: 6001494
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sensitivity testing of cytostatic agents for gynecologic tumors based on cytologic and autoradiographic evaluations (proceedings)].
    Jankowski RP; Vahrson H; Jovanovic V
    Arch Gynakol; 1977 Jul; 224(1-4):357-8. PubMed ID: 579857
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic chemotherapy in advanced age].
    Sauer H
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):M1-5. PubMed ID: 7705590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for intra-arterial cytostatic therapy of gynecologic carcinomas].
    Spechter HJ
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):808-10. PubMed ID: 5935301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects, administration forms and dosage of cytostatic agents in the treatment of gynecologic tumors. (Review)].
    Huber R
    Zentralbl Gynakol; 1967 Sep; 89(38):1377-83. PubMed ID: 4873356
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour sensitivity to cytembena in women with metastasizing gynaecological carcinoma in relation to certain inherited blood characters and serum isoenzymes.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(3):289-98. PubMed ID: 5093948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Supportive measures for cytostatic therapy of gynecologic cancers].
    Sevelda P; Vavra N; Barrada M; Seifert M; Wagner T; Salzer H
    Gynakol Rundsch; 1991; 31 Suppl 2():21-5. PubMed ID: 1724225
    [No Abstract]   [Full Text] [Related]  

  • 20. [In-vitro testing of the drug cytostasan in malignant gynecologic tumors].
    Marzotko F; Krafft W; Preibsch W; Schröder M
    Dtsch Gesundheitsw; 1973 Jan; 28(2):87-8. PubMed ID: 4724672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.